March 12, 2019
Authored and Edited by Katherine T. Leonard; Kara A. Specht; Elizabeth D. Ferrill
In University of Florida Research Foundation, Inc. v. General Electric Company, No. 18-1284 (Fed. Cir. Feb. 26, 2019), the Federal Circuit affirmed the district court’s grant of GE’s motion to dismiss UFRF’s allegations of infringement.
In 2017, UFRF sued GE alleging infringement of the ‘251 patent, which described a method and system for ‘integrat[ing] physiologic data from at least one bedside machine.” GE filed a motion to dismiss, arguing that the claims of the ‘251 patent were directed to ineligible subject matter under 35 U.S.C. § 101, which the district court granted.
On appeal, UFRF argued that the district court did not have subject matter jurisdiction to hear GE’s § 101 eligibility challenge because UFRF enjoyed sovereign immunity under the Eleventh Amendment. The Federal Circuit held that UFRF consented to federal court jurisdiction, thus waiving its Eleventh Amendment immunity, when it brought the infringement claim against GE. The Federal Circuit explained that the waiver of immunity extends not only to the cause of action but to any relevant defenses GE brought, including the §101 challenge.
After confirming subject matter jurisdiction on the §101 eligibility challenge, the Federal Circuit affirmed the district court’s finding that UFRF’s ‘251 patent was directed to an abstract idea.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
INCONTESTABLE® Blog
Netflix Prevails in Copyright Infringement Suit Regarding Tiger King
May 14, 2026
Federal Circuit IP Blog
When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case
May 14, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.